Cancer-Associated Mutations in Endometriosis without Cancer | New England Journal of Medicine | 2017 | 310 |
Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer | Cancer | 2017 | 267 |
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours | Nature Communications | 2017 | 251 |
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer | Journal of the National Cancer Institute | 2017 | 182 |
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer | European Urology | 2017 | 127 |
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome | Acta Neuropathologica | 2017 | 114 |
Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy | Clinical Cancer Research | 2017 | 89 |
Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis | Blood | 2017 | 79 |
Real-time endoscopic Raman spectroscopy for in vivo early lung cancer detection | Journal of Biophotonics | 2017 | 59 |
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial | Lancet Oncology, The | 2017 | 58 |
Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study | Histopathology | 2017 | 56 |
The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type | Journal of Pathology | 2017 | 56 |
Group 2 innate lymphoid cell activation in the neonatal lung drives type 2 immunity and allergen sensitization | Journal of Allergy and Clinical Immunology | 2017 | 55 |
Improved survival after acute graft--host disease diagnosis in the modern era | Haematologica | 2017 | 50 |
Clear cell and endometrioid carcinomas: are their differences attributable to distinct cells of origin? | Journal of Pathology | 2017 | 50 |
Variants in and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity | Clinical Cancer Research | 2017 | 47 |
Eligibility of Metastatic Pancreatic Cancer Patients for First-Line Palliative Intent nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX | American Journal of Clinical Oncology: Cancer Clinical Trials | 2017 | 45 |
Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification | Journal of Pathology: Clinical Research | 2017 | 44 |
Long-term Outcomes and Complications in Pediatric Ewing Sarcoma | American Journal of Clinical Oncology: Cancer Clinical Trials | 2017 | 43 |
Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era | British Journal of Haematology | 2017 | 40 |
Design, synthesis and evaluation of F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging | Journal of Enzyme Inhibition and Medicinal Chemistry | 2017 | 39 |
The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States | American Journal of Obstetrics and Gynecology | 2017 | 39 |
American Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy-A systematic literature review | Brachytherapy | 2017 | 37 |
Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure | Nature Reviews Urology | 2017 | 37 |
Pathogenesis and treatment of adult-type granulosa cell tumor of the ovary | Annals of Medicine | 2017 | 36 |